Case Report Overview of Ceftriaxone-Induced Hepatic Panel Abnormalities Discussion Conclusion References Another case report described an 80-year-old man who was hospitalized with painless cholestatic ...
Panelists discuss how recognizing high-risk patients and linking liver care with metabolic management can reduce both disease ...
WASHINGTON, Feb 23 (Reuters) - Salix Pharmaceuticals' diarrhea drug Xifaxan should be cleared to treat patients with a debilitating liver disorder, but more study would still be needed after approval, ...
The area under the curve (AUC) of fibrosis-4 in detection of advanced liver fibrosis (liver stiffness measurements ≥12 kPa) across the spectrum of CLivD lab (upper panel) and CLivD non-lab (lower ...
A group of Skoltech scientists led by a Skoltech and MSU professor Olga Dontsova discovered a novel liver-specific non-coding RNA. The researchers tracked the RNA amounts in a healthy liver and that ...
A new combined test panel called Lipid Profile ALT (Cholestech Corp., Hayward, Calif.) has received an FDA waiver from Clinical Laboratory Improvement Amendments (CLIA) standards. The panel, designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback